Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  12/01/2009
 
Trade Name:  Patanase
 
Generic Name or Proper Name (*):  olopatadine
 
Indications Studied:  Seasonal allergic rhinitis
 
Label Changes Summary:  Expanded age range down to 6 years; previously approved for use in 12 years and older Safety and effectiveness have not been established in < 6 years of age The incidence of epistaxis (nosebleed) was higher in children 6 -11 years of age compared to the adult and adolescent population Information on clinical trials, adverse reactions, and new one spray per nostril twice daily dosing in 6-11 years
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B) and PREA(P):  B, P
 
Sponsor:  Alcon
 
Pediatric Exclusivity Granted Date:  08/12/2009
 
NNPS:  FALSE'
 
Therapeutic Category:  Antihistamine
 
-
-